Anti-inflammatory germacrane-type sesquiterpene lactones from Vernonia sylvatica

IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE
Min WANG , Han LI , Bintao HU , Chunping TANG , Hui XU , Changqiang KE , Zuoquan XIE , Yang YE , Sheng YAO
{"title":"Anti-inflammatory germacrane-type sesquiterpene lactones from Vernonia sylvatica","authors":"Min WANG ,&nbsp;Han LI ,&nbsp;Bintao HU ,&nbsp;Chunping TANG ,&nbsp;Hui XU ,&nbsp;Changqiang KE ,&nbsp;Zuoquan XIE ,&nbsp;Yang YE ,&nbsp;Sheng YAO","doi":"10.1016/S1875-5364(24)60656-4","DOIUrl":null,"url":null,"abstract":"<div><p>Nine new germacranolides, sylvaticalides A−H (<strong>1</strong>–<strong>9</strong>), and three known analogues (<strong>10–12</strong>) were isolated from the aerial part of <em>Vernonia sylvatica</em>. Their structures were established using comprehensive spectroscopic analysis, including high-resolution electrospray ionization mass spectroscopy (HR-ESI-MS) and 1D and 2D nuclear magnetic resonance (NMR) spectra. Their absolute configurations were determined by X-ray diffraction experiments. The anti-inflammatory activities of all isolated compounds were assessed by evaluating their inhibitory effects on the nuclear factor kappa B (NF-κB) pathway, which was activated by lipopolysaccharide (LPS)-stimulated human THP1-Dual cells, and the interferon-stimulated gene (ISG) pathway, activated by STING agonist MSA-2 in the same cell model. Compounds <strong>1</strong>, <strong>2</strong> and <strong>6</strong> showed inhibitory effects on the NF-κB and ISG signaling pathways, with IC<sub>50</sub> values ranging from 4.12 to 10.57 μmol·L<sup>−1</sup>.</p></div>","PeriodicalId":10002,"journal":{"name":"Chinese Journal of Natural Medicines","volume":null,"pages":null},"PeriodicalIF":4.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Natural Medicines","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875536424606564","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Nine new germacranolides, sylvaticalides A−H (19), and three known analogues (10–12) were isolated from the aerial part of Vernonia sylvatica. Their structures were established using comprehensive spectroscopic analysis, including high-resolution electrospray ionization mass spectroscopy (HR-ESI-MS) and 1D and 2D nuclear magnetic resonance (NMR) spectra. Their absolute configurations were determined by X-ray diffraction experiments. The anti-inflammatory activities of all isolated compounds were assessed by evaluating their inhibitory effects on the nuclear factor kappa B (NF-κB) pathway, which was activated by lipopolysaccharide (LPS)-stimulated human THP1-Dual cells, and the interferon-stimulated gene (ISG) pathway, activated by STING agonist MSA-2 in the same cell model. Compounds 1, 2 and 6 showed inhibitory effects on the NF-κB and ISG signaling pathways, with IC50 values ranging from 4.12 to 10.57 μmol·L−1.

Vernonia sylvatica 中的抗炎芽胞苷类倍半萜内酯
从 Vernonia sylvatica 的气生部分分离出了九种新的胚芽鞘内酯,即 sylvaticalides A-H (1-9),以及三种已知的类似物 (10-12)。通过全面的光谱分析,包括高分辨率电喷雾电离质谱(HR-ESI-MS)以及一维和二维核磁共振(NMR)光谱,确定了它们的结构。通过 X 射线衍射实验确定了它们的绝对构型。在同一细胞模型中,通过评估它们对核因子卡巴B(NF-κB)通路(由脂多糖(LPS)刺激的人THP1-Dual细胞激活)和干扰素刺激基因(ISG)通路(由STING激动剂MSA-2激活)的抑制作用,评估了所有分离化合物的抗炎活性。化合物 1、2 和 6 对 NF-κB 和 ISG 信号通路具有抑制作用,IC50 值从 4.12 到 10.57 μmol-L-1 不等。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chinese Journal of Natural Medicines
Chinese Journal of Natural Medicines INTEGRATIVE & COMPLEMENTARY MEDICINE-PHARMACOLOGY & PHARMACY
CiteScore
7.50
自引率
4.30%
发文量
2235
期刊介绍: The Chinese Journal of Natural Medicines (CJNM), founded and sponsored in May 2003 by China Pharmaceutical University and the Chinese Pharmaceutical Association, is devoted to communication among pharmaceutical and medical scientists interested in the advancement of Traditional Chinese Medicines (TCM). CJNM publishes articles relating to a broad spectrum of bioactive natural products, leading compounds and medicines derived from Traditional Chinese Medicines (TCM). Topics covered by the journal are: Resources of Traditional Chinese Medicines; Interaction and complexity of prescription; Natural Products Chemistry (including structure modification, semi-and total synthesis, bio-transformation); Pharmacology of natural products and prescription (including pharmacokinetics and toxicology); Pharmaceutics and Analytical Methods of natural products.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信